patient_id int64 | age_years float64 | age_group string | sex string | race_ethnicity string | insurance_type string | geographic_region string | nursing_home_resident_flag int64 | prior_hospitalization_90d_flag int64 | pneumonia_type string | etiology_category string | causative_organism string | mrsa_flag int64 | drug_resistant_flag int64 | icd10_primary_code string | snomed_code int64 | chest_xray_finding string | procalcitonin_ng_ml float64 | crp_mg_l float64 | wbc_x10_9_l float64 | blood_culture_result string | urine_antigen_test string | time_to_antibiotics_hrs float64 | temperature_celsius float64 | heart_rate_bpm int64 | respiratory_rate_per_min int64 | sbp_mmhg int64 | dbp_mmhg int64 | map_mmhg float64 | spo2_pct int64 | gcs_total int64 | height_cm float64 | weight_kg float64 | bmi_kg_m2 float64 | fever_flag int64 | hypotension_flag int64 | hypoxemia_flag int64 | tachypnea_flag int64 | hemoglobin_g_dl float64 | platelet_x10_9 int64 | neutrophil_pct float64 | lymphocyte_pct float64 | neutrophil_lymphocyte_ratio float64 | sodium_meq_l float64 | bun_mg_dl float64 | urea_mmol_l float64 | creatinine_mg_dl float64 | glucose_mg_dl int64 | albumin_g_dl float64 | lactate_mmol_l float64 | d_dimer_ng_ml int64 | ferritin_ng_ml int64 | il6_pg_ml float64 | troponin_i_ng_ml float64 | aki_flag int64 | thrombocytopenia_flag int64 | hyponatremia_flag int64 | hyperglycemia_flag int64 | abg_ph float64 | abg_pao2_mmhg int64 | abg_paco2_mmhg float64 | abg_hco3_meq_l float64 | abg_sao2_pct float64 | abg_lactate_mmol_l float64 | fio2_decimal float64 | respiratory_acidosis_flag int64 | metabolic_acidosis_flag int64 | curb65_score int64 | curb65_confusion_flag int64 | curb65_urea_flag int64 | curb65_rr_flag int64 | curb65_sbp_flag int64 | curb65_age_flag int64 | psi_score int64 | psi_risk_class string | smart_cop_score int64 | sofa_score int64 | sofa_respiratory int64 | sofa_coagulation int64 | sofa_liver int64 | sofa_cardiovascular int64 | sofa_renal int64 | sofa_cns int64 | apache_ii_score int64 | news2_score int64 | pf_ratio int64 | ards_berlin_category string | sepsis_flag int64 | septic_shock_flag int64 | ats_major_criteria_flag int64 | severity_final string | oxygen_delivery_device string | intubation_flag int64 | intubation_timing_hours float64 | ventilator_days float64 | tidal_volume_ml_kg_ibw float64 | peep_cmh2o float64 | driving_pressure_cmh2o float64 | plateau_pressure_cmh2o float64 | prone_positioning_flag int64 | ecmo_flag int64 | niv_flag int64 | hfnc_flag int64 | sbt_flag int64 | extubation_success_flag int64 | reintubation_flag int64 | empiric_regimen string | antibiotic_1_name string | antibiotic_1_dose_mg int64 | antibiotic_1_frequency string | antibiotic_1_route string | antibiotic_1_duration_days int64 | antibiotic_2_flag int64 | antibiotic_2_name string | antibiotic_escalation_flag int64 | antibiotic_de_escalation_flag int64 | antibiotic_oral_switch_flag int64 | corticosteroid_flag int64 | corticosteroid_indication string | dexamethasone_dose_mg float64 | antiviral_flag int64 | antifungal_flag int64 | vasopressor_flag int64 | c_diff_flag int64 | procalcitonin_serial_flag int64 | procalcitonin_nadir_ng_ml float64 | copd_flag int64 | heart_failure_flag int64 | diabetes_flag int64 | ckd_flag int64 | cad_flag int64 | immunosuppression_flag int64 | hiv_flag int64 | malignancy_flag int64 | smoking_status string | alcohol_use_flag int64 | clinical_frailty_score int64 | influenza_vaccine string | pneumococcal_vaccine string | aspiration_risk_flag int64 | icu_admission_flag int64 | icu_los_days float64 | hospital_los_days float64 | inpatient_mortality_flag int64 | time_to_death_days float64 | mortality_30d_flag int64 | mortality_90d_flag int64 | pleural_effusion_flag int64 | empyema_flag int64 | aki_hospital_flag int64 | new_onset_afib_flag int64 | secondary_bacteremia_flag int64 | discharge_disposition string | readmission_30d_flag int64 | readmission_90d_flag int64 | time_to_clinical_stability_days float64 | total_hospital_cost_usd int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 42 | Adult | Male | White | Private | Suburban | 0 | 1 | CAP | Atypical | C_pneumoniae | 0 | 0 | J18.9 | 233,604,007 | Lobar_Consolidation | 0.188 | 69.1 | 6.7 | Negative | Pneumococcal_pos | 0.5 | 37.7 | 70 | 38 | 79 | 70 | 73 | 89 | 11 | 158 | 89.2 | 35.7 | 0 | 1 | 1 | 1 | 12.5 | 155 | 84.2 | 20.2 | 4.2 | 132.2 | 28 | 10 | 2.28 | 162 | 3.1 | 3.6 | 375 | 731 | 41.6 | 0.094 | 1 | 0 | 1 | 0 | 7.34 | 122 | 29.1 | 20.3 | 86.4 | 3.3 | 0.66 | 0 | 1 | 4 | 1 | 1 | 1 | 1 | 0 | 56 | II | 6 | 7 | 1 | 1 | 0 | 2 | 1 | 2 | 21 | 8 | 184 | Moderate | 0 | 0 | 0 | Critical | NIV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | CAP_ICU | Ceftriaxone | 2,000 | q24h | IV | 5 | 1 | Azithromycin | 0 | 1 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 0.047 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | Never | 0 | 2 | Current | Both | 0 | 0 | 0 | 3.9 | 1 | 3.4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | Died | 0 | 0 | 2.1 | 43,154 |
2 | 68.4 | Elderly | Female | White | Medicare | Urban | 1 | 0 | HAP | Bacterial | K_pneumoniae_MDR | 0 | 0 | J18.9 | 64,667,001 | Multilobar | 8.451 | 12.2 | 13.8 | Positive | Pneumococcal_pos | 0.4 | 37.7 | 123 | 41 | 104 | 60 | 74.7 | 80 | 13 | 163.5 | 60.6 | 22.7 | 0 | 0 | 1 | 1 | 12.6 | 137 | 86.2 | 12.2 | 7.1 | 133.9 | 21.7 | 7.8 | 1.85 | 203 | 2.9 | 3.5 | 608 | 3,431 | 23.8 | 1.515 | 1 | 0 | 1 | 1 | 7.41 | 100 | 36.5 | 26.6 | 90.9 | 0.5 | 0.49 | 0 | 0 | 4 | 1 | 1 | 1 | 0 | 1 | 103 | IV | 4 | 5 | 2 | 1 | 1 | 0 | 0 | 1 | 8 | 6 | 203 | Mild | 0 | 0 | 0 | Critical | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 9 | 0 | null | 1 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 2.466 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | Current | 0 | 4 | Prior_Year | Neither | 0 | 0 | 0 | 3.9 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | LTAC_or_SNF | 1 | 0 | 3.7 | 5,000 |
3 | 76 | Elderly | Female | White | Private | Suburban | 0 | 0 | HAP | Bacterial | S_aureus_MSSA | 0 | 0 | J15.21 | 64,667,001 | Patchy_Infiltrate | 10.343 | 235.8 | 19.7 | Negative | Negative | 5.6 | 41.5 | 99 | 18 | 111 | 55 | 73.7 | 94 | 11 | 177 | 83 | 26.5 | 1 | 0 | 0 | 0 | 6.3 | 222 | 94 | 13.2 | 7.1 | 132.1 | 52.3 | 18.7 | 1.68 | 206 | 1.8 | 3.2 | 189 | 7,782 | 32.6 | 0.15 | 1 | 0 | 1 | 1 | 7.27 | 40 | 30.5 | 22.1 | 88.6 | 6.1 | 0.52 | 0 | 0 | 3 | 1 | 1 | 0 | 0 | 1 | 121 | IV | 3 | 7 | 3 | 1 | 0 | 1 | 0 | 2 | 17 | 7 | 50 | Severe | 1 | 1 | 1 | Critical | IMV_ECMO | 1 | 4.3 | 19.8 | 5.5 | 5.2 | 17.8 | 17.8 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 6 | 0 | null | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 2.895 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | Never | 0 | 7 | Current | Neither | 0 | 1 | 7.1 | 7.3 | 0 | null | 0 | 0 | 1 | 1 | 0 | 0 | 0 | LTAC_or_SNF | 0 | 0 | 2.1 | 60,662 |
4 | 70.6 | Elderly | Female | Hispanic | Uninsured | Urban | 0 | 0 | HAP | Bacterial | E_coli | 0 | 1 | J18.9 | 64,667,001 | Lobar_Consolidation | 3.773 | 48.8 | 16.4 | Negative | Negative | 1.6 | 40.5 | 160 | 15 | 90 | 73 | 78.7 | 88 | 11 | 167.6 | 99.5 | 35.4 | 1 | 0 | 1 | 0 | 17.7 | 217 | 74.7 | 13.3 | 5.6 | 138.2 | 15.5 | 5.5 | 1.67 | 141 | 3.1 | 3.4 | 989 | 118 | 5.2 | 0.822 | 1 | 0 | 0 | 0 | 7.32 | 137 | 37.7 | 16 | 88.5 | 3.7 | 0.67 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 95 | IV | 5 | 5 | 1 | 2 | 0 | 0 | 0 | 2 | 18 | 5 | 203 | Mild | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 7 | 1 | Azithromycin | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 1.244 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Never | 0 | 5 | Current | PCV13_only | 0 | 0 | 0 | 6.2 | 0 | null | 0 | 0 | 1 | 0 | 1 | 0 | 0 | Home_with_Services | 1 | 1 | 1.4 | 17,416 |
5 | 3.5 | Pediatric | Male | White | Medicare | Urban | 0 | 0 | CAP | Fungal | P_jirovecii | 0 | 0 | J18.9 | 233,604,007 | Patchy_Infiltrate | 0.169 | 46.2 | 15 | Negative | Pneumococcal_pos | 9.5 | 40.5 | 97 | 27 | 139 | 49 | 79 | 91 | 9 | 178.9 | 54.2 | 16.9 | 1 | 0 | 1 | 1 | 13.5 | 192 | 75.4 | 15.6 | 4.8 | 136.2 | 28 | 10 | 2.61 | 129 | 2.4 | 1.5 | 4,581 | 73 | 355.7 | 0.314 | 1 | 0 | 0 | 0 | 7.52 | 41 | 29.3 | 16.6 | 89.4 | 0.5 | 0.83 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 40 | I | 4 | 10 | 4 | 0 | 0 | 2 | 1 | 3 | 30 | 4 | 50 | Severe | 1 | 0 | 1 | Critical | IMV | 1 | 16.5 | 14.2 | 6.5 | 10.6 | 20.8 | 16.6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_ICU | Ceftriaxone | 2,000 | q24h | IV | 10 | 1 | Azithromycin | 0 | 0 | 1 | 1 | COVID_O2_Requiring | 10.3 | 0 | 1 | 1 | 0 | 1 | 0.018 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | Current | 1 | 2 | Current | Neither | 0 | 1 | 1.7 | 1.9 | 1 | 0.6 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | Died | 0 | 0 | 1.6 | 28,288 |
6 | 43.9 | Adult | Male | Asian | Uninsured | Urban | 1 | 0 | HAP | Bacterial | S_aureus_MRSA | 1 | 0 | J15.212 | 64,667,001 | Lobar_Consolidation | 10.071 | 144 | 7 | Contaminated | Negative | 4.8 | 38.4 | 143 | 28 | 123 | 79 | 93.7 | 92 | 13 | 151.4 | 81.4 | 35.5 | 1 | 0 | 0 | 1 | 11.2 | 247 | 88.5 | 7.4 | 11.9 | 140.9 | 30.5 | 10.9 | 1.88 | 60 | 2.8 | 2.6 | 159 | 693 | 16.2 | 1.536 | 1 | 0 | 0 | 0 | 7.36 | 132 | 38.2 | 15.6 | 95 | 2 | 0.55 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 12 | I | 4 | 5 | 2 | 1 | 0 | 0 | 1 | 1 | 14 | 5 | 241 | Mild | 1 | 0 | 0 | Moderate | NIV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 13 | 1 | Azithromycin | 1 | 0 | 1 | 1 | COVID_O2_Requiring | 6 | 0 | 0 | 0 | 0 | 0 | 1.081 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Never | 0 | 1 | Current | PCV13_only | 0 | 0 | 0 | 1.5 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | Home_with_Services | 0 | 0 | 3.1 | 22,491 |
7 | 70 | Elderly | Male | White | Uninsured | Rural | 0 | 0 | HAP | Bacterial | S_aureus_MRSA | 1 | 0 | J15.212 | 64,667,001 | Patchy_Infiltrate | 2.275 | 331.9 | 14.4 | Negative | Negative | 0.6 | 39.4 | 126 | 28 | 70 | 71 | 70.7 | 90 | 13 | 164.6 | 109.5 | 40.4 | 1 | 1 | 1 | 1 | 9.5 | 125 | 78.8 | 15.2 | 5.2 | 142.5 | 32.3 | 11.5 | 2.22 | 157 | 3.3 | 2.5 | 1,046 | 882 | 14.7 | 0.101 | 1 | 0 | 0 | 0 | 7.41 | 174 | 41 | 25.7 | 86.5 | 4.5 | 0.61 | 0 | 0 | 4 | 1 | 1 | 0 | 1 | 1 | 114 | IV | 8 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 24 | 6 | 285 | Mild | 1 | 1 | 1 | Critical | IMV | 1 | 19.4 | 13.3 | 6 | 4.6 | 18.7 | 20.2 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 9 | 0 | Vancomycin | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 1 | 0 | 1 | 0.289 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | Former | 0 | 5 | Current | Neither | 0 | 1 | 2.1 | 2.3 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 0 | LTAC_or_SNF | 0 | 0 | 1 | 38,610 |
8 | 60.5 | Adult | Male | Hispanic | Medicaid | Suburban | 0 | 0 | CAP | Viral | Influenza_A | 0 | 0 | J09.X1 | 233,604,007 | Multilobar | 0.072 | 202.6 | 15.1 | Negative | Negative | 0.5 | 38.2 | 84 | 27 | 80 | 66 | 70.7 | 91 | 11 | 146.7 | 52 | 24.1 | 0 | 1 | 1 | 1 | 13.8 | 122 | 75.6 | 11 | 6.9 | 139.4 | 17.5 | 6.2 | 1.51 | 110 | 2.7 | 3.8 | 1,163 | 60 | 42.4 | 0.05 | 1 | 0 | 0 | 0 | 7.48 | 136 | 38.1 | 28.4 | 89.9 | 4.8 | 0.47 | 0 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 103 | IV | 6 | 4 | 0 | 0 | 0 | 2 | 0 | 2 | 17 | 4 | 291 | Mild | 1 | 0 | 0 | Moderate | Room_Air | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 8 | 1 | Azithromycin | 0 | 1 | 1 | 0 | null | 0 | 1 | 0 | 0 | 0 | 0 | 0.028 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Current | 0 | 1 | Current | Neither | 0 | 0 | 0 | 3 | 0 | null | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Home_with_Services | 1 | 0 | 6.8 | 17,837 |
9 | 6 | Pediatric | Male | Hispanic | Private | Urban | 0 | 0 | CAP | Viral | Influenza_A | 0 | 0 | J09.X1 | 233,604,007 | Patchy_Infiltrate | 0.274 | 26.2 | 10.3 | Negative | Negative | 4.7 | 38 | 112 | 25 | 88 | 67 | 74 | 91 | 13 | 163.3 | 105.4 | 39.5 | 0 | 1 | 1 | 1 | 12.4 | 147 | 94.2 | 9.4 | 10.1 | 137.5 | 9.6 | 3.4 | 3.24 | 179 | 2.6 | 4 | 424 | 471 | 42.6 | 0.567 | 1 | 0 | 0 | 0 | 7.31 | 91 | 36.3 | 26.1 | 88.6 | 2.4 | 0.5 | 0 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 50 | I | 6 | 8 | 2 | 2 | 0 | 2 | 1 | 1 | 17 | 6 | 183 | Moderate | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 8 | 0 | null | 0 | 0 | 1 | 0 | null | 0 | 1 | 0 | 0 | 0 | 0 | 0.048 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | Current | 0 | 1 | Never | Neither | 0 | 0 | 0 | 8.1 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | Home_with_Services | 0 | 0 | 2.6 | 13,150 |
10 | 78.1 | Elderly | Male | White | Private | Suburban | 1 | 0 | HAP | Fungal | Candida_spp | 0 | 1 | J18.9 | 64,667,001 | Patchy_Infiltrate | 0.449 | 75 | 17.6 | Negative | Negative | 5.2 | 38.4 | 117 | 20 | 140 | 56 | 84 | 87 | 13 | 156.5 | 115.6 | 47.2 | 1 | 0 | 1 | 0 | 12 | 156 | 66.5 | 20.6 | 3.2 | 139.6 | 18.5 | 6.6 | 2.29 | 140 | 3.3 | 3.3 | 2,161 | 903 | 11.2 | 0.037 | 1 | 0 | 0 | 0 | 7.4 | 153 | 41.3 | 22.1 | 96.4 | 0.5 | 0.43 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | 107 | IV | 5 | 6 | 0 | 1 | 0 | 2 | 2 | 1 | 25 | 5 | 355 | null | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 11 | 1 | Azithromycin | 0 | 1 | 0 | 1 | CAP_Severe | 6 | 0 | 1 | 0 | 0 | 1 | 0.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Current | 0 | 2 | Prior_Year | Both | 0 | 0 | 0 | 7.2 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | Home_with_Services | 1 | 0 | 3.9 | 11,869 |
11 | 87.2 | Elderly | Male | Hispanic | Private | Urban | 1 | 0 | CAP | Viral | Influenza_A | 0 | 0 | J09.X1 | 233,604,007 | Lobar_Consolidation | 0.038 | 23.1 | 18.8 | Negative | Pneumococcal_pos | 4.4 | 40.1 | 99 | 21 | 127 | 79 | 95 | 86 | 10 | 182.1 | 75.1 | 22.7 | 1 | 0 | 1 | 0 | 12.7 | 54 | 95 | 9.3 | 10.2 | 138.5 | 15.3 | 5.5 | 2.41 | 145 | 3.7 | 4.9 | 252 | 58 | 9.5 | 0.163 | 1 | 1 | 0 | 0 | 7.51 | 59 | 46.4 | 16.9 | 92.5 | 4.5 | 0.43 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | 118 | IV | 5 | 8 | 2 | 1 | 1 | 1 | 1 | 2 | 17 | 4 | 137 | Moderate | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 9 | 0 | null | 0 | 0 | 1 | 1 | COVID_O2_Requiring | 20 | 1 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Current | 0 | 8 | Never | Neither | 0 | 0 | 0 | 1.2 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Home_with_Services | 0 | 1 | 3.8 | 24,319 |
12 | 91.9 | Elderly | Female | White | Medicaid | Urban | 0 | 0 | HAP | Bacterial | S_aureus_MSSA | 0 | 0 | J15.21 | 64,667,001 | Patchy_Infiltrate | 12.645 | 191 | 12.2 | Negative | Negative | 4.2 | 39.8 | 121 | 24 | 138 | 71 | 93.3 | 89 | 11 | 172.5 | 72.5 | 24.3 | 1 | 0 | 1 | 1 | 11.3 | 151 | 74.9 | 19.6 | 3.8 | 136.3 | 49.5 | 17.7 | 1.06 | 191 | 2.9 | 2.2 | 449 | 96 | 27 | 1.109 | 0 | 0 | 0 | 1 | 7.4 | 85 | 34.4 | 17.9 | 92.6 | 3.4 | 0.63 | 0 | 0 | 3 | 1 | 1 | 0 | 0 | 1 | 108 | IV | 5 | 4 | 1 | 0 | 1 | 0 | 0 | 2 | 17 | 5 | 136 | Moderate | 0 | 0 | 0 | Severe | Simple_Mask | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 9 | 1 | Azithromycin | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 1 | 0 | 0 | 2.763 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Never | 0 | 2 | Current | Both | 0 | 0 | 0 | 2.7 | 0 | null | 0 | 0 | 1 | 0 | 1 | 0 | 0 | SNF_or_Rehab | 0 | 1 | 2.7 | 28,989 |
13 | 84.7 | Elderly | Female | Hispanic | Medicare | Urban | 0 | 0 | CAP | Atypical | M_pneumoniae | 0 | 0 | J15.7 | 233,604,007 | Lobar_Consolidation | 0.042 | 66.1 | 18 | Positive | Negative | 8.5 | 38 | 117 | 28 | 112 | 74 | 86.7 | 88 | 11 | 179.2 | 102.7 | 32 | 0 | 0 | 1 | 1 | 12.6 | 276 | 88.8 | 15.9 | 5.6 | 136.5 | 53.8 | 19.2 | 1.59 | 169 | 4 | 1.4 | 127 | 139 | 141.5 | 0.016 | 1 | 0 | 0 | 0 | 7.53 | 85 | 39 | 18.7 | 99 | 0.5 | 0.46 | 0 | 0 | 3 | 1 | 1 | 0 | 0 | 1 | 118 | IV | 6 | 7 | 0 | 0 | 2 | 1 | 2 | 2 | 16 | 6 | 184 | Moderate | 1 | 0 | 0 | Severe | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 9 | 0 | null | 0 | 0 | 1 | 1 | COVID_O2_Requiring | 12 | 0 | 0 | 0 | 0 | 1 | 0.015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Former | 0 | 2 | Never | Neither | 0 | 0 | 0 | 2.2 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SNF_or_Rehab | 0 | 0 | 2 | 5,000 |
14 | 63.4 | Adult | Male | White | Uninsured | Rural | 0 | 1 | CAP | Bacterial | H_influenzae | 0 | 0 | J14 | 233,604,007 | Lobar_Consolidation | 66.333 | 122.8 | 14.4 | Negative | Pneumococcal_pos | 7.5 | 38.8 | 117 | 23 | 104 | 75 | 84.7 | 95 | 12 | 163.3 | 75.9 | 28.5 | 1 | 0 | 0 | 1 | 13 | 244 | 80.1 | 4.1 | 19.3 | 131.9 | 29.3 | 10.5 | 1.67 | 155 | 2.5 | 2.3 | 630 | 323 | 59.9 | 0.294 | 1 | 0 | 1 | 0 | 7.33 | 221 | 43.9 | 21.8 | 100 | 3.3 | 0.69 | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 78 | III | 1 | 6 | 0 | 1 | 0 | 0 | 3 | 2 | 13 | 2 | 320 | null | 0 | 0 | 0 | Moderate | NIV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 4 | 0 | null | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 18.969 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Never | 0 | 1 | Prior_Year | Both | 0 | 0 | 0 | 2.4 | 0 | null | 0 | 0 | 1 | 0 | 1 | 0 | 0 | Home_with_Services | 0 | 0 | 1.8 | 13,808 |
15 | 70.3 | Elderly | Male | Black | Private | Suburban | 0 | 0 | CAP | Viral | Influenza_A | 0 | 0 | J09.X1 | 233,604,007 | Interstitial | 0.07 | 62 | 20.2 | Positive | Negative | 2.2 | 39.6 | 103 | 22 | 88 | 62 | 70.7 | 92 | 13 | 156.8 | 28.2 | 11.5 | 1 | 1 | 0 | 1 | 12.4 | 233 | 83.1 | 23.2 | 3.6 | 139.9 | 10.5 | 3.8 | 2.01 | 222 | 2.5 | 0.5 | 443 | 1,079 | 19.7 | 0.634 | 1 | 0 | 0 | 1 | 7.49 | 53 | 39.7 | 28.1 | 95 | 3.1 | 0.47 | 0 | 0 | 3 | 1 | 0 | 0 | 1 | 1 | 92 | IV | 7 | 5 | 3 | 0 | 0 | 1 | 0 | 1 | 21 | 5 | 113 | Moderate | 0 | 0 | 0 | Severe | NIV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 9 | 0 | null | 0 | 1 | 0 | 1 | COVID_O2_Requiring | 9.2 | 1 | 0 | 0 | 0 | 1 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Former | 0 | 2 | Never | PCV13_only | 0 | 0 | 0 | 2.1 | 1 | 1.7 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | Died | 0 | 0 | 6.5 | 21,749 |
16 | 76.5 | Elderly | Female | Other | Medicaid | Suburban | 0 | 0 | HAP | Unknown | Unknown | 0 | 1 | J18.9 | 64,667,001 | Patchy_Infiltrate | 0.934 | 72.3 | 26 | Negative | Negative | 5 | 38.8 | 90 | 31 | 109 | 48 | 68.3 | 85 | 14 | 156.4 | 77.8 | 31.8 | 1 | 0 | 1 | 1 | 11.7 | 183 | 79.9 | 14.2 | 5.6 | 135 | 43 | 15.4 | 2.95 | 198 | 2.2 | 1.2 | 1,629 | 351 | 192.7 | 0.247 | 1 | 0 | 0 | 1 | 7.35 | 149 | 21.5 | 26.7 | 91.4 | 3 | 0.56 | 0 | 0 | 4 | 1 | 1 | 1 | 0 | 1 | 102 | IV | 6 | 4 | 0 | 1 | 1 | 1 | 0 | 1 | 14 | 6 | 265 | Mild | 0 | 0 | 0 | Critical | IMV | 1 | 9.6 | 7.2 | 7.6 | 6.4 | 15.6 | 20 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 5 | 1 | Azithromycin | 0 | 0 | 1 | 1 | CAP_Severe | 10.7 | 0 | 0 | 0 | 0 | 0 | 0.32 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Former | 0 | 4 | Current | Neither | 0 | 0 | 0 | 1.4 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | LTAC_or_SNF | 0 | 1 | 1 | 14,700 |
17 | 66.8 | Elderly | Female | White | Medicare | Urban | 0 | 0 | HAP | Bacterial | K_pneumoniae_MDR | 0 | 0 | J18.9 | 64,667,001 | Patchy_Infiltrate | 20.709 | 240.9 | 9.2 | Contaminated | Negative | 2.8 | 39.1 | 103 | 24 | 106 | 81 | 89.3 | 89 | 10 | 170.9 | 90.3 | 30.9 | 1 | 0 | 1 | 1 | 14.4 | 294 | 89.3 | 17 | 5.3 | 142.1 | 16.7 | 6 | 2.01 | 140 | 2.3 | 3.5 | 225 | 442 | 25.3 | 0.053 | 1 | 0 | 0 | 0 | 7.36 | 43 | 31 | 20.3 | 87.2 | 1.3 | 0.66 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | 74 | III | 3 | 8 | 3 | 1 | 1 | 0 | 1 | 2 | 30 | 5 | 65 | Severe | 1 | 0 | 1 | Critical | Simple_Mask | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 9 | 0 | null | 0 | 0 | 0 | 1 | ARDS | 6 | 0 | 0 | 0 | 0 | 1 | 7.889 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Never | 1 | 6 | Never | PCV13_only | 0 | 1 | 4.6 | 7.2 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | LTAC_or_SNF | 0 | 0 | 5.3 | 13,205 |
18 | 0 | Pediatric | Female | Hispanic | Medicare | Urban | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Lobar_Consolidation | 4.049 | 44.5 | 17.6 | Negative | Negative | 0.5 | 39.1 | 102 | 27 | 111 | 80 | 90.3 | 93 | 13 | 187.9 | 96.3 | 27.3 | 1 | 0 | 0 | 1 | 8.9 | 133 | 75.7 | 22.5 | 3.4 | 140.9 | 17.2 | 6.1 | 0.94 | 133 | 3.5 | 0.5 | 146 | 8,921 | 22.9 | 0.081 | 0 | 0 | 0 | 0 | 7.44 | 47 | 41.3 | 14.3 | 95.7 | 0.9 | 0.42 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 25 | I | 2 | 5 | 3 | 0 | 1 | 0 | 0 | 1 | 12 | 5 | 111 | Moderate | 0 | 0 | 0 | Mild | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Mild_Outpatient | Amoxicillin | 1,000 | q8h | PO | 6 | 0 | null | 1 | 0 | 0 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 1.213 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Current | 0 | 2 | Current | PPSV23_only | 1 | 0 | 0 | 1.6 | 0 | null | 0 | 0 | 1 | 1 | 0 | 0 | 0 | Home | 0 | 1 | 5.5 | 8,010 |
19 | 77.4 | Elderly | Male | Black | Private | Suburban | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Interstitial | 18.172 | 185.3 | 20.8 | Positive | Negative | 8.7 | 39.2 | 68 | 19 | 141 | 64 | 89.7 | 91 | 12 | 172.5 | 60.6 | 20.4 | 1 | 0 | 1 | 0 | 10.3 | 132 | 74.3 | 24.5 | 3 | 134.2 | 18.8 | 6.7 | 1.3 | 184 | 2.8 | 0.6 | 705 | 85 | 22.4 | 0.05 | 0 | 0 | 1 | 1 | 7.38 | 104 | 33.6 | 18.1 | 93.2 | 1.7 | 0.45 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | 115 | IV | 5 | 4 | 1 | 0 | 0 | 0 | 1 | 2 | 8 | 5 | 233 | Mild | 1 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 10 | 0 | null | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 4.684 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | Never | 0 | 6 | Current | PCV13_only | 0 | 0 | 0 | 3 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | Home_with_Services | 0 | 0 | 1.8 | 26,259 |
20 | 64.1 | Adult | Female | White | Private | Urban | 0 | 0 | CAP | Bacterial | K_pneumoniae | 0 | 0 | J15.0 | 233,604,007 | Lobar_Consolidation | 3.993 | 118.5 | 9.4 | Negative | Negative | 0.5 | 39.1 | 105 | 17 | 110 | 76 | 87.3 | 92 | 11 | 163.9 | 74.1 | 27.6 | 1 | 0 | 0 | 0 | 11.9 | 279 | 95 | 16.8 | 5.7 | 141.8 | 20.1 | 7.2 | 1.92 | 160 | 2.5 | 2 | 2,137 | 133 | 42.2 | 0.146 | 1 | 0 | 0 | 0 | 7.39 | 144 | 44.7 | 27.5 | 96.6 | 2.7 | 0.46 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 68 | II | 3 | 3 | 0 | 0 | 0 | 0 | 1 | 2 | 11 | 4 | 309 | null | 1 | 0 | 0 | Moderate | Simple_Mask | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 8 | 1 | Azithromycin | 0 | 0 | 1 | 1 | COVID_O2_Requiring | 7.3 | 0 | 0 | 0 | 0 | 0 | 1.138 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Former | 1 | 2 | Current | PPSV23_only | 0 | 0 | 0 | 1.5 | 0 | null | 0 | 0 | 1 | 0 | 1 | 0 | 0 | Home_with_Services | 0 | 1 | 2.3 | 10,822 |
21 | 54.1 | Adult | Male | Black | Private | Rural | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Patchy_Infiltrate | 0.695 | 151.3 | 11.3 | Negative | Pneumococcal_pos | 5.8 | 38.3 | 100 | 24 | 137 | 86 | 103 | 91 | 13 | 165.9 | 101.5 | 36.9 | 0 | 0 | 1 | 1 | 10.5 | 203 | 80.1 | 19.4 | 4.1 | 126.6 | 21.4 | 7.7 | 1.93 | 107 | 3.5 | 1.5 | 821 | 952 | 8.4 | 0.093 | 1 | 0 | 1 | 0 | 7.42 | 58 | 47.3 | 23.8 | 91.7 | 3.3 | 0.63 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 68 | II | 3 | 5 | 2 | 0 | 1 | 0 | 1 | 1 | 30 | 3 | 93 | Severe | 1 | 0 | 1 | Critical | Simple_Mask | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_ICU | Ceftriaxone | 2,000 | q24h | IV | 5 | 0 | null | 1 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0.214 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | Never | 0 | 1 | Current | Neither | 0 | 0 | 0 | 4 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | LTAC_or_SNF | 0 | 0 | 4.1 | 6,649 |
22 | 58.8 | Adult | Male | Black | Medicare | Suburban | 0 | 1 | HCAP | Bacterial | K_pneumoniae | 0 | 0 | J15.0 | 422,400,008 | Interstitial | 27.217 | 201.3 | 11.2 | Positive | Negative | 0.5 | 38.4 | 78 | 25 | 84 | 85 | 84.7 | 86 | 13 | 167.7 | 78.7 | 28 | 1 | 1 | 1 | 1 | 11.1 | 154 | 73.1 | 17.9 | 4.1 | 144.5 | 10.1 | 3.6 | 1.66 | 188 | 3.7 | 3.5 | 3,593 | 1,532 | 3 | 0.071 | 1 | 0 | 0 | 1 | 7.28 | 56 | 32.6 | 21.4 | 94 | 0.5 | 0.49 | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 100 | IV | 6 | 6 | 1 | 2 | 1 | 1 | 0 | 1 | 23 | 3 | 114 | Moderate | 0 | 0 | 0 | Moderate | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 7 | 1 | Azithromycin | 0 | 0 | 0 | 1 | CAP_Severe | 6.1 | 0 | 0 | 0 | 0 | 1 | 9.547 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Never | 0 | 1 | Never | Neither | 0 | 0 | 0 | 2.9 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Home_with_Services | 1 | 0 | 3.8 | 14,780 |
23 | 74.5 | Elderly | Male | Other | Medicare | Urban | 0 | 0 | CAP | Viral | SARS_CoV2 | 0 | 0 | J12.82 | 233,604,007 | Patchy_Infiltrate | 0.03 | 70.6 | 14.3 | Positive | Pneumococcal_pos | 0.9 | 38.1 | 100 | 21 | 156 | 62 | 93.3 | 81 | 9 | 190.3 | 46.4 | 12.8 | 0 | 0 | 1 | 0 | 14.1 | 227 | 66.2 | 12 | 5.5 | 130.7 | 21.4 | 7.7 | 2.05 | 210 | 3.6 | 2.9 | 1,047 | 823 | 114.3 | 0.316 | 1 | 0 | 1 | 1 | 7.32 | 152 | 28.7 | 20.3 | 93.7 | 3.2 | 0.68 | 0 | 1 | 3 | 1 | 1 | 0 | 0 | 1 | 107 | IV | 5 | 4 | 0 | 0 | 1 | 0 | 0 | 3 | 18 | 9 | 225 | Mild | 1 | 0 | 0 | Severe | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 15 | 1 | Azithromycin | 0 | 1 | 1 | 1 | COVID_O2_Requiring | 6 | 1 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | Former | 0 | 6 | Never | PCV13_only | 0 | 0 | 0 | 2.3 | 0 | null | 0 | 0 | 1 | 0 | 0 | 0 | 0 | SNF_or_Rehab | 0 | 0 | 6.5 | 12,333 |
24 | 65 | Elderly | Male | Other | Private | Suburban | 0 | 0 | CAP | Viral | Influenza_A | 0 | 0 | J09.X1 | 233,604,007 | Multilobar | 0.079 | 69.9 | 12.3 | Positive | Negative | 5.8 | 37.4 | 95 | 29 | 107 | 54 | 71.7 | 90 | 13 | 181.6 | 107.2 | 32.5 | 0 | 0 | 1 | 1 | 11.7 | 172 | 95 | 6.4 | 14.8 | 138.9 | 37.4 | 13.4 | 1.54 | 198 | 3.7 | 0.8 | 690 | 5,030 | 145.5 | 0.825 | 1 | 0 | 0 | 1 | 7.44 | 40 | 34.2 | 20 | 100 | 2.8 | 0.41 | 0 | 0 | 3 | 1 | 1 | 0 | 0 | 1 | 79 | III | 4 | 6 | 4 | 0 | 0 | 1 | 0 | 1 | 21 | 6 | 50 | Severe | 1 | 0 | 0 | Severe | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 3 | 0 | null | 0 | 1 | 1 | 0 | null | 0 | 1 | 0 | 1 | 0 | 0 | 0.019 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Former | 0 | 4 | Prior_Year | Neither | 0 | 0 | 0 | 7.6 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | SNF_or_Rehab | 0 | 1 | 5.6 | 5,000 |
25 | 70.1 | Elderly | Male | White | Medicare | Rural | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Lobar_Consolidation | 1.03 | 165.1 | 14.1 | Negative | Negative | 1.3 | 39 | 142 | 35 | 120 | 52 | 74.7 | 92 | 10 | 170.9 | 75.3 | 25.8 | 1 | 0 | 0 | 1 | 7.8 | 127 | 75.8 | 15.1 | 5 | 137.6 | 30.1 | 10.8 | 2.19 | 223 | 2.6 | 4.3 | 1,284 | 741 | 6.3 | 0.282 | 1 | 0 | 0 | 1 | 7.43 | 131 | 32.1 | 17.1 | 97.2 | 3.1 | 0.67 | 0 | 0 | 4 | 1 | 1 | 1 | 0 | 1 | 115 | IV | 6 | 8 | 0 | 2 | 1 | 1 | 2 | 2 | 20 | 8 | 196 | Moderate | 0 | 0 | 0 | Critical | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | CAP_ICU | Ceftriaxone | 2,000 | q24h | IV | 8 | 1 | Azithromycin | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 0.117 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Current | 0 | 2 | Current | PCV13_only | 0 | 1 | 5.3 | 6 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | LTAC_or_SNF | 0 | 0 | 1.6 | 39,941 |
26 | 75.1 | Elderly | Male | Hispanic | Uninsured | Urban | 0 | 0 | HCAP | Atypical | M_pneumoniae | 0 | 0 | J15.7 | 422,400,008 | Patchy_Infiltrate | 0.498 | 101.6 | 18.9 | Negative | Negative | 2 | 39.8 | 109 | 22 | 125 | 65 | 85 | 89 | 12 | 169.2 | 104 | 36.3 | 1 | 0 | 1 | 1 | 10.8 | 131 | 95 | 22.8 | 4.2 | 140.7 | 30.3 | 10.8 | 2.24 | 240 | 3.3 | 3.7 | 2,948 | 21 | 33.1 | 0.831 | 1 | 0 | 0 | 1 | 7.4 | 201 | 44.4 | 30.5 | 96.8 | 2 | 0.54 | 0 | 0 | 3 | 1 | 1 | 0 | 0 | 1 | 93 | IV | 5 | 4 | 0 | 0 | 1 | 0 | 1 | 2 | 27 | 3 | 374 | null | 1 | 0 | 1 | Critical | Simple_Mask | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_ICU | Ceftriaxone | 2,000 | q24h | IV | 5 | 1 | Azithromycin | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | Current | 1 | 5 | Current | Neither | 0 | 0 | 0 | 3.4 | 1 | 7.9 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | Died | 0 | 0 | 7.6 | 23,691 |
27 | 59.4 | Adult | Female | Hispanic | Medicare | Suburban | 0 | 0 | CAP | Unknown | Unknown | 0 | 0 | J18.9 | 233,604,007 | Multilobar | 0.815 | 52.2 | 5.2 | Negative | Pneumococcal_pos | 3 | 37.7 | 123 | 32 | 101 | 87 | 91.7 | 95 | 14 | 171.3 | 49.3 | 16.8 | 0 | 0 | 0 | 1 | 11.8 | 216 | 84.6 | 18.2 | 4.6 | 135 | 5 | 1.8 | 2.13 | 226 | 3.4 | 0.5 | 2,081 | 463 | 11.9 | 1.051 | 1 | 0 | 0 | 1 | 7.4 | 40 | 29.2 | 29.2 | 95 | 4.6 | 0.6 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 120 | IV | 2 | 5 | 2 | 1 | 0 | 0 | 1 | 1 | 19 | 3 | 50 | Severe | 1 | 0 | 0 | Moderate | Room_Air | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 12 | 1 | Azithromycin | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 1 | 1 | 0.065 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Current | 1 | 1 | Current | Neither | 0 | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Home_with_Services | 0 | 0 | 2.2 | 30,080 |
28 | 2.3 | Pediatric | Male | White | Medicare | Rural | 1 | 0 | HAP | Bacterial | Enterobacter_spp | 0 | 0 | J18.9 | 64,667,001 | Patchy_Infiltrate | 13.931 | 169.2 | 10.6 | Negative | Negative | 13.6 | 39.5 | 107 | 15 | 120 | 58 | 78.7 | 88 | 12 | 173.4 | 77.3 | 25.7 | 1 | 0 | 1 | 0 | 11.4 | 195 | 83.3 | 6.7 | 12.4 | 127 | 43.5 | 15.6 | 2.23 | 178 | 2.8 | 3.5 | 176 | 216 | 152.8 | 0.108 | 1 | 0 | 1 | 0 | 7.39 | 170 | 38.6 | 18.3 | 88.4 | 5.2 | 0.69 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 21 | I | 3 | 7 | 1 | 0 | 1 | 2 | 1 | 2 | 22 | 4 | 248 | Mild | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 10 | 1 | Azithromycin | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 1 | 0 | 0 | 4.249 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Current | 0 | 2 | Prior_Year | PCV13_only | 0 | 0 | 0 | 3.9 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Home_with_Services | 0 | 0 | 1 | 21,655 |
29 | 5.4 | Pediatric | Male | White | Medicare | Urban | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Patchy_Infiltrate | 0.654 | 126.3 | 17.1 | Positive | Negative | 0.6 | 39.4 | 65 | 27 | 131 | 65 | 87 | 97 | 14 | 163.5 | 91.2 | 34.1 | 1 | 0 | 0 | 1 | 13.2 | 314 | 80.9 | 23.1 | 3.5 | 135.9 | 15.6 | 5.6 | 1.35 | 139 | 3.4 | 0.7 | 865 | 2,446 | 18.2 | 0.154 | 0 | 0 | 0 | 0 | 7.46 | 47 | 45.1 | 16.2 | 97.1 | 1.3 | 0.3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 23 | I | 2 | 6 | 3 | 1 | 1 | 0 | 0 | 1 | 23 | 2 | 154 | Moderate | 0 | 0 | 0 | Mild | Room_Air | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Mild_Outpatient | Amoxicillin | 1,000 | q8h | PO | 9 | 0 | null | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 1 | 0 | 0 | 0.26 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | Current | 0 | 1 | Current | PCV13_only | 1 | 0 | 0 | 6 | 0 | null | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Home | 0 | 0 | 1 | 7,585 |
30 | 46.5 | Adult | Male | Other | Private | Rural | 0 | 0 | CAP | Fungal | P_jirovecii | 0 | 0 | J18.9 | 233,604,007 | Lobar_Consolidation | 0.02 | 72.5 | 17.2 | Negative | Negative | 0.8 | 37.3 | 115 | 20 | 98 | 63 | 74.7 | 95 | 12 | 158.7 | 78.1 | 31 | 0 | 0 | 0 | 0 | 12.7 | 176 | 95 | 13.2 | 7.2 | 135.7 | 40.8 | 14.6 | 1.69 | 82 | 2.6 | 1.3 | 606 | 1,617 | 3,042.5 | 0.089 | 1 | 0 | 0 | 0 | 7.3 | 137 | 40.6 | 23.2 | 89.4 | 2.3 | 0.49 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 21 | I | 1 | 4 | 1 | 0 | 0 | 1 | 0 | 2 | 9 | 5 | 279 | Mild | 1 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 11 | 1 | Azithromycin | 0 | 0 | 0 | 1 | ARDS | 6 | 0 | 1 | 0 | 0 | 0 | 0.01 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | Never | 0 | 1 | Prior_Year | Both | 0 | 0 | 0 | 1.8 | 0 | null | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Home_with_Services | 0 | 0 | 5.2 | 17,207 |
31 | 86.6 | Elderly | Male | White | Private | Urban | 0 | 0 | HAP | Bacterial | S_aureus_MSSA | 1 | 0 | J15.21 | 64,667,001 | Interstitial | 1.628 | 160.5 | 11 | Positive | Negative | 2.6 | 39.2 | 102 | 34 | 87 | 58 | 67.7 | 91 | 11 | 179.4 | 54 | 16.8 | 1 | 1 | 1 | 1 | 10.6 | 146 | 61.3 | 2 | 30.6 | 126.5 | 38.1 | 13.6 | 2.24 | 173 | 2.5 | 6.6 | 713 | 60 | 46 | 0.051 | 1 | 0 | 1 | 0 | 7.31 | 180 | 35.4 | 20.2 | 87.4 | 5 | 0.76 | 0 | 1 | 5 | 1 | 1 | 1 | 1 | 1 | 143 | V | 8 | 6 | 1 | 1 | 1 | 1 | 0 | 2 | 15 | 9 | 237 | Mild | 1 | 0 | 0 | Critical | IMV_ECMO | 1 | 0.5 | 12.4 | 5.8 | 9.4 | 15.5 | 24.1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 9 | 1 | Azithromycin | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 0.332 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | Former | 0 | 5 | Current | Neither | 0 | 0 | 0 | 2.9 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | LTAC_or_SNF | 1 | 1 | 12.5 | 5,000 |
32 | 57.5 | Adult | Male | Hispanic | Private | Suburban | 0 | 0 | CAP | Bacterial | Legionella_pneumophila | 0 | 0 | J15.0 | 233,604,007 | Multilobar | 0.809 | 137.2 | 17.2 | Negative | Pneumococcal_pos | 0.9 | 40.4 | 97 | 19 | 112 | 70 | 84 | 86 | 14 | 168.2 | 27.5 | 9.7 | 1 | 0 | 1 | 0 | 9.4 | 298 | 82.4 | 21.3 | 3.9 | 136.8 | 20.3 | 7.2 | 1.3 | 175 | 3.4 | 2.5 | 100 | 2,824 | 197.7 | 0.22 | 0 | 0 | 0 | 0 | 7.38 | 146 | 34.8 | 25.1 | 99.8 | 4.2 | 0.61 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 95 | IV | 3 | 4 | 2 | 0 | 1 | 0 | 0 | 1 | 14 | 5 | 239 | Mild | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 8 | 1 | Azithromycin | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 0.239 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | Never | 0 | 1 | Current | Both | 1 | 0 | 0 | 8.6 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Home_with_Services | 0 | 0 | 1.5 | 19,945 |
33 | 40.2 | Adult | Male | Asian | Uninsured | Suburban | 0 | 0 | HAP | Bacterial | P_aeruginosa | 1 | 0 | J15.1 | 64,667,001 | Patchy_Infiltrate | 5.966 | 291.3 | 22.3 | Negative | Negative | 1.4 | 39.8 | 91 | 27 | 102 | 51 | 68 | 88 | 12 | 178.4 | 113.5 | 35.7 | 1 | 0 | 1 | 1 | 10.3 | 246 | 79.6 | 7 | 11.3 | 131.1 | 13.1 | 4.7 | 2.59 | 168 | 3.7 | 3 | 111 | 2,211 | 544.8 | 0.067 | 1 | 0 | 1 | 0 | 7.37 | 197 | 44.9 | 24.8 | 91.8 | 2.1 | 0.74 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 11 | I | 4 | 7 | 2 | 0 | 1 | 2 | 0 | 2 | 25 | 0 | 267 | Mild | 0 | 0 | 0 | Mild | Room_Air | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 6 | 0 | Vancomycin | 1 | 0 | 1 | 1 | Refractory_Shock | 11.1 | 0 | 0 | 0 | 0 | 0 | 0.361 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Former | 0 | 1 | Current | Both | 0 | 0 | 0 | 2.3 | 1 | 6.2 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | Died | 0 | 0 | 1 | 18,858 |
34 | 49.3 | Adult | Male | White | Medicare | Suburban | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Multilobar | 3.002 | 209.1 | 14.4 | Negative | Negative | 0.3 | 37.3 | 106 | 20 | 135 | 83 | 100.3 | 95 | 12 | 186.1 | 85.5 | 24.7 | 0 | 0 | 0 | 0 | 10.4 | 203 | 78.5 | 25.4 | 3.1 | 138.9 | 54.4 | 19.4 | 1.48 | 81 | 3.7 | 2.7 | 308 | 248 | 52.8 | 0.286 | 0 | 0 | 0 | 0 | 7.25 | 73 | 33.9 | 17.7 | 92.9 | 1 | 0.51 | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 4 | I | 1 | 7 | 2 | 1 | 1 | 1 | 0 | 2 | 15 | 3 | 142 | Moderate | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 7 | 1 | Azithromycin | 0 | 0 | 1 | 1 | COVID_O2_Requiring | 10.8 | 0 | 0 | 0 | 0 | 1 | 0.612 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Current | 0 | 2 | Current | PCV13_only | 0 | 0 | 0 | 5.4 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | Home_with_Services | 0 | 0 | 4.8 | 7,523 |
35 | 49.7 | Adult | Female | Hispanic | Medicaid | Urban | 0 | 0 | HAP | Bacterial | S_aureus_MRSA | 1 | 0 | J15.212 | 64,667,001 | Patchy_Infiltrate | 12.254 | 153.2 | 10.2 | Negative | Negative | 0.6 | 39.8 | 127 | 25 | 118 | 66 | 83.3 | 90 | 12 | 173.7 | 105.7 | 35 | 1 | 0 | 1 | 1 | 10.8 | 74 | 83.1 | 20.3 | 4.1 | 134.7 | 41.1 | 14.7 | 2.55 | 151 | 3.4 | 4.3 | 105 | 432 | 38.7 | 0.032 | 1 | 1 | 1 | 0 | 7.29 | 138 | 40 | 26.8 | 91.9 | 3.4 | 0.74 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 19 | I | 4 | 6 | 2 | 0 | 0 | 1 | 1 | 2 | 18 | 4 | 187 | Moderate | 1 | 0 | 0 | Moderate | Simple_Mask | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 7 | 1 | Azithromycin | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 4.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Former | 0 | 1 | Never | Neither | 0 | 0 | 0 | 3 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 1 | Home_with_Services | 0 | 1 | 1.2 | 10,615 |
36 | 65.8 | Elderly | Female | Other | Medicare | Suburban | 0 | 0 | HAP | Unknown | Unknown | 0 | 0 | J18.9 | 64,667,001 | Patchy_Infiltrate | 0.132 | 102.5 | 19.6 | Negative | Pneumococcal_pos | 3.8 | 38.5 | 125 | 35 | 105 | 98 | 100.3 | 91 | 10 | 171.9 | 100.4 | 34 | 1 | 0 | 1 | 1 | 12.8 | 127 | 78.9 | 12.2 | 6.5 | 143.6 | 41.4 | 14.8 | 2.08 | 188 | 3.1 | 1.9 | 392 | 3,835 | 40.1 | 0.244 | 1 | 0 | 0 | 1 | 7.37 | 111 | 33.5 | 20.4 | 90.3 | 1.3 | 0.47 | 0 | 0 | 4 | 1 | 1 | 1 | 0 | 1 | 112 | IV | 4 | 8 | 2 | 0 | 0 | 3 | 1 | 2 | 21 | 7 | 237 | Mild | 0 | 0 | 0 | Critical | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 8 | 0 | null | 0 | 1 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | Former | 0 | 6 | Prior_Year | PPSV23_only | 0 | 1 | 9.8 | 10.5 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | LTAC_or_SNF | 0 | 0 | 6 | 22,090 |
37 | 1.9 | Pediatric | Male | Hispanic | Medicare | Urban | 0 | 0 | HAP | Bacterial | S_aureus_MRSA | 1 | 1 | J15.212 | 64,667,001 | Lobar_Consolidation | 1.806 | 108.1 | 24 | Negative | Negative | 4.8 | 39.9 | 138 | 26 | 116 | 53 | 74 | 83 | 10 | 200 | 93.1 | 23.3 | 1 | 0 | 1 | 1 | 12.1 | 107 | 83.8 | 15.9 | 5.3 | 134.5 | 54 | 19.3 | 2.62 | 123 | 3 | 2.3 | 1,523 | 26 | 41.1 | 0.033 | 1 | 0 | 1 | 0 | 7.42 | 65 | 23.1 | 24 | 81.5 | 0.5 | 0.39 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 15 | I | 4 | 6 | 1 | 0 | 0 | 2 | 1 | 2 | 12 | 4 | 168 | Moderate | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 3 | 0 | Vancomycin | 0 | 0 | 1 | 1 | COVID_O2_Requiring | 10.2 | 0 | 0 | 0 | 0 | 0 | 0.507 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | Former | 0 | 1 | Prior_Year | Both | 0 | 0 | 0 | 4.4 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Home_with_Services | 0 | 0 | 2.7 | 18,713 |
38 | 59.9 | Adult | Female | White | Private | Urban | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Patchy_Infiltrate | 0.255 | 149.4 | 10.3 | Negative | Negative | 1.6 | 38.4 | 136 | 35 | 72 | 88 | 82.7 | 98 | 14 | 170.3 | 72.9 | 25.2 | 1 | 1 | 0 | 1 | 13.3 | 195 | 80.5 | 29.1 | 2.8 | 138 | 31.2 | 11.2 | 2.17 | 164 | 2.4 | 3.6 | 241 | 797 | 133.7 | 0.365 | 1 | 0 | 0 | 0 | 7.35 | 68 | 33.6 | 21.2 | 86.8 | 1.3 | 0.47 | 0 | 0 | 4 | 1 | 1 | 1 | 1 | 0 | 121 | IV | 4 | 9 | 2 | 3 | 1 | 0 | 2 | 1 | 22 | 8 | 145 | Moderate | 0 | 0 | 0 | Critical | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | CAP_ICU | Ceftriaxone | 2,000 | q24h | IV | 11 | 0 | null | 0 | 0 | 0 | 1 | ARDS | 6 | 0 | 0 | 0 | 0 | 1 | 0.067 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Never | 0 | 2 | Current | Both | 0 | 1 | 3.1 | 6.3 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | LTAC_or_SNF | 0 | 0 | 1.6 | 68,617 |
39 | 74.3 | Elderly | Female | White | Medicare | Urban | 0 | 0 | HAP | Bacterial | E_coli | 1 | 0 | J18.9 | 64,667,001 | Interstitial | 0.326 | 157.6 | 14.5 | Negative | Negative | 1.8 | 38.8 | 65 | 21 | 101 | 87 | 91.7 | 88 | 14 | 156 | 90.8 | 37.3 | 1 | 0 | 1 | 0 | 11.1 | 163 | 66.9 | 21.4 | 3.1 | 135.9 | 42.7 | 15.2 | 2.07 | 170 | 2.8 | 0.5 | 453 | 1,857 | 4.9 | 0.086 | 1 | 0 | 0 | 0 | 7.35 | 111 | 35 | 26.4 | 95.4 | 2.9 | 0.61 | 0 | 0 | 3 | 1 | 1 | 0 | 0 | 1 | 85 | III | 5 | 4 | 1 | 0 | 1 | 0 | 1 | 1 | 18 | 5 | 182 | Moderate | 0 | 0 | 0 | Severe | NIV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 14 | 1 | Azithromycin | 1 | 1 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0.096 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | Current | 1 | 4 | Never | Both | 0 | 0 | 0 | 1.1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SNF_or_Rehab | 0 | 0 | 2.8 | 5,000 |
40 | 70.1 | Elderly | Female | Other | Private | Suburban | 0 | 0 | HCAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 422,400,008 | Patchy_Infiltrate | 38.777 | 92.7 | 20.3 | Negative | Negative | 0.2 | 38.6 | 84 | 33 | 113 | 64 | 80.3 | 82 | 12 | 164.9 | 111.5 | 41 | 1 | 0 | 1 | 1 | 14.6 | 301 | 84.9 | 15.6 | 5.4 | 129.6 | 23.7 | 8.5 | 1.71 | 204 | 2.7 | 4.2 | 145 | 379 | 21.9 | 0.097 | 1 | 0 | 1 | 1 | 7.41 | 73 | 34.1 | 12.7 | 87.8 | 5 | 0.39 | 0 | 0 | 4 | 1 | 1 | 1 | 0 | 1 | 119 | IV | 6 | 9 | 2 | 1 | 1 | 3 | 0 | 2 | 18 | 8 | 188 | Moderate | 0 | 0 | 0 | Critical | IMV | 1 | 2.8 | 17.5 | 5.7 | 8.3 | 11.6 | 20.9 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | CAP_ICU | Ceftriaxone | 2,000 | q24h | IV | 7 | 1 | Azithromycin | 1 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 5.198 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | Never | 0 | 4 | Current | PPSV23_only | 0 | 0 | 0 | 9.8 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | LTAC_or_SNF | 0 | 0 | 8.8 | 5,000 |
41 | 69.7 | Elderly | Female | White | Private | Urban | 0 | 0 | CAP | Bacterial | H_influenzae | 0 | 0 | J14 | 233,604,007 | Lobar_Consolidation | 54.616 | 207.1 | 14.7 | Contaminated | Negative | 6.3 | 38.8 | 69 | 15 | 133 | 66 | 88.3 | 90 | 15 | 185.1 | 81.8 | 23.9 | 1 | 0 | 1 | 0 | 13.3 | 91 | 87 | 33.1 | 2.6 | 136 | 34.5 | 12.3 | 1.77 | 220 | 3.6 | 0.5 | 552 | 910 | 10.7 | 0.5 | 1 | 1 | 0 | 1 | 7.37 | 40 | 32.2 | 25.8 | 92.8 | 1 | 0.28 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 1 | 75 | III | 2 | 5 | 3 | 0 | 0 | 0 | 2 | 0 | 23 | 5 | 50 | Severe | 0 | 0 | 0 | Moderate | Simple_Mask | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 12 | 0 | null | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 5.949 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | Never | 0 | 1 | Current | Neither | 0 | 0 | 0 | 5 | 0 | null | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Home_with_Services | 0 | 0 | 1 | 5,000 |
42 | 71.1 | Elderly | Female | Hispanic | Medicaid | Urban | 0 | 1 | CAP | Bacterial | H_influenzae | 0 | 0 | J14 | 233,604,007 | Patchy_Infiltrate | 5.009 | 144.6 | 5.3 | Negative | Pneumococcal_pos | 5.3 | 38.3 | 112 | 21 | 117 | 60 | 79 | 82 | 14 | 153.8 | 121.8 | 51.5 | 0 | 0 | 1 | 0 | 12.2 | 122 | 74.2 | 16.7 | 4.4 | 140 | 17.5 | 6.3 | 1.88 | 135 | 3.8 | 1.6 | 676 | 387 | 1.1 | 0.084 | 1 | 0 | 0 | 0 | 7.45 | 72 | 40.1 | 19.7 | 88.7 | 1.8 | 0.23 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | 91 | IV | 5 | 6 | 1 | 2 | 1 | 1 | 0 | 1 | 21 | 5 | 306 | null | 0 | 0 | 0 | Moderate | NIV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 8 | 0 | null | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 1 | 0 | 0 | 0.28 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | Never | 0 | 4 | Prior_Year | Neither | 0 | 0 | 0 | 4.3 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | Died | 0 | 0 | 6.2 | 16,458 |
43 | 74.2 | Elderly | Female | White | Private | Rural | 0 | 0 | HAP | Bacterial | S_maltophilia | 1 | 1 | J18.9 | 64,667,001 | Interstitial | 1.668 | 155.1 | 18.1 | Negative | Negative | 8.9 | 39.2 | 99 | 25 | 128 | 55 | 79.3 | 83 | 11 | 159.7 | 47 | 18.4 | 1 | 0 | 1 | 1 | 12.3 | 191 | 95 | 15.7 | 6 | 137.5 | 28.3 | 10.1 | 1.66 | 176 | 3.3 | 1.1 | 140 | 179 | 200.9 | 0.296 | 1 | 0 | 0 | 0 | 7.34 | 50 | 37.8 | 21.4 | 86.2 | 3.7 | 0.7 | 0 | 1 | 3 | 1 | 1 | 0 | 0 | 1 | 96 | IV | 6 | 9 | 4 | 0 | 1 | 2 | 0 | 2 | 26 | 7 | 72 | Severe | 0 | 0 | 1 | Critical | IMV_ECMO | 1 | 4.9 | 4.4 | 7 | 12.2 | 19 | 23.7 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 6 | 0 | Vancomycin | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0.364 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Current | 0 | 4 | Current | PCV13_only | 1 | 0 | 0 | 2.5 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 1 | LTAC_or_SNF | 1 | 0 | 6.6 | 21,228 |
44 | 33.4 | Adult | Female | Hispanic | Private | Urban | 0 | 1 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Multilobar | 3.133 | 140.2 | 8.9 | Negative | Negative | 4.9 | 37.7 | 91 | 30 | 130 | 72 | 91.3 | 100 | 12 | 180.2 | 44.6 | 13.8 | 0 | 0 | 0 | 1 | 10.7 | 243 | 92.7 | 10.8 | 8.6 | 136 | 25.2 | 9 | 2.26 | 157 | 3.9 | 0.5 | 137 | 93 | 64.2 | 0.089 | 1 | 0 | 0 | 0 | 7.33 | 64 | 34.9 | 28.2 | 94 | 0.9 | 0.25 | 0 | 0 | 3 | 1 | 1 | 1 | 0 | 0 | 29 | I | 2 | 5 | 1 | 1 | 0 | 1 | 0 | 2 | 17 | 3 | 255 | Mild | 1 | 0 | 0 | Severe | IMV | 1 | 3.9 | 6.3 | 7.7 | 3 | 11.2 | 30.4 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 7 | 1 | Azithromycin | 0 | 0 | 1 | 1 | ARDS | 12.6 | 0 | 0 | 0 | 0 | 1 | 0.362 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | Former | 0 | 1 | Never | PCV13_only | 0 | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | SNF_or_Rehab | 0 | 0 | 2.2 | 11,186 |
45 | 59.5 | Adult | Male | Other | Private | Urban | 0 | 0 | HAP | Bacterial | S_maltophilia | 0 | 0 | J18.9 | 64,667,001 | Lobar_Consolidation | 12.785 | 387.1 | 7.9 | Negative | Pneumococcal_pos | 0.6 | 39.3 | 98 | 24 | 103 | 71 | 81.7 | 89 | 15 | 165 | 101.7 | 37.4 | 1 | 0 | 1 | 1 | 7.7 | 20 | 88.5 | 5.4 | 16.3 | 130.9 | 11.1 | 4 | 2.76 | 179 | 3.3 | 4.2 | 100 | 1,040 | 6.9 | 0.25 | 1 | 1 | 1 | 0 | 7.47 | 41 | 34.1 | 19.5 | 96.7 | 1.1 | 0.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 | I | 2 | 6 | 1 | 1 | 1 | 2 | 1 | 0 | 14 | 1 | 78 | Severe | 1 | 0 | 0 | Mild | Room_Air | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 8 | 1 | Azithromycin | 1 | 0 | 1 | 1 | ARDS | 11.5 | 0 | 0 | 0 | 0 | 0 | 3.553 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | Former | 0 | 2 | Never | PCV13_only | 0 | 0 | 0 | 4.6 | 0 | null | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Home | 1 | 1 | 5 | 10,394 |
46 | 32.3 | Adult | Male | Hispanic | Medicare | Urban | 0 | 0 | HAP | Bacterial | P_aeruginosa | 0 | 0 | J15.1 | 64,667,001 | Lobar_Consolidation | 2.417 | 133.6 | 6.9 | Negative | Negative | 8.1 | 39.4 | 117 | 17 | 102 | 48 | 66 | 83 | 13 | 166.8 | 62 | 22.3 | 1 | 0 | 1 | 0 | 10 | 57 | 90.4 | 11.1 | 8.1 | 138 | 36.8 | 13.2 | 2.76 | 187 | 2.5 | 4.8 | 1,264 | 204 | 210.5 | 0.805 | 1 | 1 | 0 | 1 | 7.43 | 53 | 27.6 | 17.6 | 94.3 | 3.8 | 0.54 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 19 | I | 3 | 7 | 2 | 0 | 1 | 2 | 1 | 1 | 18 | 6 | 98 | Severe | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | HAP_Non_VAP | Piperacillin_Tazobactam | 4,500 | q6h | IV | 6 | 0 | null | 0 | 0 | 1 | 1 | CAP_Severe | 6 | 0 | 0 | 0 | 0 | 1 | 0.585 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Never | 0 | 2 | Current | Neither | 0 | 0 | 0 | 4.4 | 0 | null | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Home_with_Services | 0 | 0 | 4.1 | 6,562 |
47 | 65.5 | Elderly | Male | Other | Medicare | Urban | 0 | 0 | CAP | Unknown | Unknown | 0 | 0 | J18.9 | 233,604,007 | Patchy_Infiltrate | 1.729 | 105.5 | 19.3 | Positive | Negative | 3.3 | 37.2 | 70 | 14 | 124 | 101 | 108.7 | 93 | 15 | 179.8 | 125 | 38.6 | 0 | 0 | 0 | 0 | 13.8 | 195 | 78.9 | 17.4 | 4.5 | 139.3 | 18.2 | 6.5 | 1.6 | 201 | 3.4 | 3.2 | 349 | 28 | 1 | 0.262 | 1 | 0 | 0 | 1 | 7.35 | 73 | 38.9 | 22.1 | 92.1 | 0.5 | 0.29 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 70 | II | 0 | 3 | 2 | 0 | 0 | 1 | 0 | 0 | 15 | 2 | 249 | Mild | 0 | 0 | 0 | Mild | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Mild_Outpatient | Amoxicillin | 1,000 | q8h | PO | 10 | 0 | null | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 0.591 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | Never | 0 | 4 | Current | PPSV23_only | 0 | 0 | 0 | 5.3 | 0 | null | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Home | 0 | 0 | 6.5 | 22,288 |
48 | 64.9 | Adult | Male | White | Private | Suburban | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Lobar_Consolidation | 4.414 | 68 | 8.9 | Negative | Negative | 9.5 | 39.4 | 72 | 15 | 111 | 71 | 84.3 | 90 | 15 | 160.1 | 109.4 | 42.7 | 1 | 0 | 1 | 0 | 12.6 | 313 | 89.6 | 19.8 | 4.5 | 141.3 | 5 | 1.8 | 1.34 | 60 | 3.1 | 0.5 | 239 | 302 | 8.2 | 0.049 | 0 | 0 | 0 | 0 | 7.44 | 40 | 46.1 | 22.2 | 97 | 0.5 | 0.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69 | II | 2 | 3 | 2 | 0 | 1 | 0 | 0 | 0 | 10 | 0 | 149 | Moderate | 1 | 0 | 0 | Mild | HFNC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | CAP_Mild_Outpatient | Amoxicillin | 1,000 | q8h | PO | 6 | 0 | null | 0 | 0 | 0 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 1.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Never | 0 | 4 | Current | Both | 0 | 0 | 0 | 8.1 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 0 | Home | 0 | 0 | 2.8 | 15,328 |
49 | 80.7 | Elderly | Male | Hispanic | Uninsured | Urban | 0 | 1 | CAP | Atypical | C_pneumoniae | 0 | 0 | J18.9 | 233,604,007 | Multilobar | 0.902 | 2 | 16.5 | Negative | Negative | 2.2 | 38.9 | 105 | 30 | 136 | 70 | 92 | 93 | 10 | 151.8 | 114.9 | 49.8 | 1 | 0 | 0 | 1 | 11.3 | 323 | 95 | 5.9 | 16.1 | 135.1 | 23.5 | 8.4 | 1.74 | 175 | 3.5 | 1.1 | 430 | 194 | 21.5 | 0.718 | 1 | 0 | 0 | 0 | 7.36 | 40 | 43.4 | 18 | 86 | 2.3 | 0.54 | 0 | 0 | 4 | 1 | 1 | 1 | 0 | 1 | 118 | IV | 4 | 5 | 2 | 0 | 0 | 1 | 0 | 2 | 18 | 7 | 57 | Severe | 1 | 0 | 0 | Critical | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_ICU | Ceftriaxone | 2,000 | q24h | IV | 5 | 1 | Azithromycin | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 0.159 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | Never | 0 | 5 | Prior_Year | Both | 0 | 0 | 0 | 4.1 | 0 | null | 0 | 0 | 1 | 0 | 1 | 0 | 0 | LTAC_or_SNF | 0 | 1 | 1 | 18,316 |
50 | 2.9 | Pediatric | Male | Asian | Medicare | Urban | 0 | 0 | CAP | Bacterial | S_pneumoniae | 0 | 0 | J13 | 233,604,007 | Patchy_Infiltrate | 2.383 | 273.6 | 17.2 | Negative | Negative | 0.5 | 39 | 124 | 28 | 91 | 63 | 72.3 | 87 | 11 | 152.7 | 99.5 | 42.6 | 1 | 0 | 1 | 1 | 10.1 | 169 | 88.2 | 19.3 | 4.6 | 129.9 | 22.6 | 8.1 | 1.62 | 173 | 3.1 | 2.8 | 617 | 61 | 21.6 | 0.047 | 1 | 0 | 1 | 0 | 7.42 | 66 | 32.3 | 23.1 | 93 | 2.8 | 0.38 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 26 | I | 4 | 4 | 2 | 0 | 0 | 0 | 0 | 2 | 11 | 4 | 173 | Moderate | 0 | 0 | 0 | Moderate | Nasal_Cannula | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CAP_Inpatient_Non_ICU | Ceftriaxone | 1,000 | q24h | IV | 8 | 0 | null | 1 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 0 | 1 | 0.366 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | Former | 0 | 3 | Current | PCV13_only | 0 | 0 | 0 | 1 | 0 | null | 0 | 0 | 0 | 0 | 1 | 0 | 1 | Home_with_Services | 0 | 1 | 7.9 | 11,881 |
YAML Metadata Warning:The task_categories "survival-analysis" is not in the official list: text-classification, token-classification, table-question-answering, question-answering, zero-shot-classification, translation, summarization, feature-extraction, text-generation, fill-mask, sentence-similarity, text-to-speech, text-to-audio, automatic-speech-recognition, audio-to-audio, audio-classification, audio-text-to-text, voice-activity-detection, depth-estimation, image-classification, object-detection, image-segmentation, text-to-image, image-to-text, image-to-image, image-to-video, unconditional-image-generation, video-classification, reinforcement-learning, robotics, tabular-classification, tabular-regression, tabular-to-text, table-to-text, multiple-choice, text-ranking, text-retrieval, time-series-forecasting, text-to-video, image-text-to-text, image-text-to-image, image-text-to-video, visual-question-answering, document-question-answering, zero-shot-image-classification, graph-ml, mask-generation, zero-shot-object-detection, text-to-3d, image-to-3d, image-feature-extraction, video-text-to-text, keypoint-detection, visual-document-retrieval, any-to-any, video-to-video, other
HC-RES-003 — Pneumonia Synthetic Dataset (Sample)
XpertSystems.ai · Synthetic Data Factory · Respiratory Vertical
The third SKU in the XpertSystems Respiratory vertical: a clinically detailed synthetic pneumonia cohort spanning Community-Acquired (CAP), Hospital-Acquired (HAP), Ventilator-Associated (VAP), and Healthcare-Associated (HCAP) pneumonia. It covers organism taxonomy & resistance (MRSA/MDR), full severity scoring (CURB-65, PSI/Fine, SMART-COP, SOFA, APACHE-II, NEWS2, ARDS Berlin), vitals, labs & ABG, respiratory support (HFNC/NIV/IMV/ECMO, lung-protective ventilation), guideline-based antibiotic regimens, comorbidities, and hospitalization outcomes (ICU, mortality, complications, readmission, cost).
This repository contains a 500-row, single-seed sample. The full commercial product scales to 20,000+ patients with CSV / Parquet / JSON delivery.
- SKU: HC-RES-003
- Sample size: 500 patients × 157 columns
- License (sample): CC-BY-NC-4.0 — commercial license available for the full product
- Contact: pradeep@xpertsystems.ai · https://xpertsystems.ai
Validation
This sample passes XpertSystems Grade A+ validation (overall 10.000 / 10) with
deterministic reproduction across all six canonical seeds [42, 7, 123, 2024, 99, 1].
Validation philosophy: structural identities over distribution-fit tests — including the VAP > CAP mortality gradient and the procalcitonin bacterial-vs-viral separation as structural floors. This engine also passes its own built-in ~15-check benchmark suite (CAP/HAP/VAP distribution, PSI Class-V mortality, CURB-65=0 mortality, ICU/intubation rates, ARDS PF ratio).
Calibration anchors
| Metric | Sample value | Target range | Source |
|---|---|---|---|
| CAP prevalence | 67.4% | 60–71% | ATS/IDSA 2019 (~60-70%) |
| HAP prevalence | 22.0% | 18–28% | Hospital-acquired epidemiology |
| VAP prevalence | 7.2% | 5–11% | Ventilator-associated epidemiology |
| ICU admission rate | 21.8% | 15–30% | ATS/IDSA (~18-26%) |
| Intubation rate | 22.2% | 14–27% | VAP-adjusted |
| 30-day mortality | ~8.8% | 5–12% | Overall pneumonia mortality |
| 30-day readmission | ~16.5% | 13–24% | CMS HRRP (~18%) |
| Median hospital LOS | 4.1 days | 3.5–8 | CAP/HAP LOS literature |
| VAP − CAP mortality gradient | +0.11 | ≥0.03 | Severity ordering (physiology) |
| VAP > CAP mortality holds | yes | boolean | Severity ordering |
| PCT bacterial / viral ratio | 23.5× | ≥3× | Procalcitonin biomarker separation |
| Column count | 157 | ≥150 | Schema completeness (10 modules) |
Schema highlights by module (157 columns)
Demographics. Bimodal age (pediatric + adult/elderly), sex, race, insurance, region, nursing-home residence, prior 90-day hospitalization.
Classification. Pneumonia type (CAP/HAP/VAP/HCAP), etiology category, causative organism (type- specific taxonomies), MRSA & MDR flags, ICD-10 & SNOMED, chest X-ray finding, procalcitonin, CRP, WBC, blood culture, urine antigen, time-to-antibiotics.
Vitals. Temperature, HR, RR, SBP/DBP/MAP, SpO2, GCS, BMI, plus fever/hypotension/hypoxemia/ tachypnea flags.
Severity scores. CURB-65 (+ component flags), PSI/Fine score & risk class, SMART-COP, SOFA (6 subscores + total), APACHE-II, NEWS2, PF ratio, ARDS Berlin category, sepsis & septic-shock flags, ATS major criteria, final severity.
Laboratory. CBC, neutrophil/lymphocyte ratio, electrolytes, BUN/urea, creatinine, glucose, albumin, lactate, D-dimer, ferritin, IL-6, troponin, plus AKI/thrombocytopenia/hyponatremia/ hyperglycemia flags.
ABG. FiO2, PaO2, PaCO2, pH, HCO3, lactate, SaO2.
Respiratory support. O2 delivery device (Room Air → IMV-ECMO), intubation timing, ventilator days, lung-protective settings (tidal volume, PEEP, driving/plateau pressure), prone positioning, ECMO, NIV, HFNC, spontaneous breathing trial, extubation success, reintubation.
Antibiotics. Guideline-based empiric regimen, primary & secondary agents (dose/freq/route/ duration), PCT-guided de-escalation, oral switch, corticosteroids (indication, dexamethasone dose), antiviral/antifungal, vasopressors, C. diff, serial procalcitonin.
Comorbidities. COPD, heart failure, diabetes, CKD, CAD, immunosuppression, HIV, malignancy, smoking, alcohol, frailty, vaccinations, aspiration risk.
Outcomes. ICU admission & LOS, hospital LOS, inpatient/30d/90d mortality, time to death, complications (pleural effusion, empyema, AKI, new AF, bacteremia), discharge disposition, 30/90-day readmission, time to clinical stability, total cost.
Files
hc_res_003_sample.csv— 500-patient sample (157 columns)generate_sample_dataset_hc_res_003.py— reproducible generator + validation harnessvalidation_report.json/validation_report.md— full scorecardsweep_summary.json— 6-seed determinism results
Loading
import pandas as pd
df = pd.read_csv("hc_res_003_sample.csv")
print(df[["patient_id","pneumonia_type","severity_final","curb65_score",
"psi_risk_class","icu_admission_flag","mortality_30d_flag"]].head())
from datasets import load_dataset
ds = load_dataset("csv", data_files="hc_res_003_sample.csv")
Use cases
- Pneumonia severity triage (CURB-65 / PSI / SMART-COP score replication & calibration)
- Mortality and ICU-admission risk prediction
- Antibiotic-stewardship and PCT-guided de-escalation modeling
- Bacterial-vs-viral etiology classification from biomarkers
- ARDS / respiratory-failure progression and ventilation-outcome modeling
- Readmission-risk and cost modeling
- ML training where real pneumonia EHR data is PHI-restricted
Honest limitations & disclosed generator behavior
This is a strongly calibrated single-table engine (passes its own ~15-check suite; correct severity and biomarker gradients). Standard caveats:
- Cross-sectional snapshot. Unlike the asthma (HC-RES-001) and COPD (HC-RES-002) SKUs, this is a single admission-level table — there is no longitudinal trajectory or per-event companion table. Each row is one pneumonia episode.
- Severity proxy drives correlated modules. Vitals, labs, and ABG are generated from a single 0–1 severity proxy (seeded by pneumonia type), so they co-move cleanly with severity but encode somewhat tighter within-patient coupling than messy real-world data.
- Some comorbidity/complication flags are marginal draws. Drawn at fixed (age-adjusted where relevant) prevalences rather than jointly conditioned on the full clinical picture.
- Mortality is a calibrated Bernoulli.
inpatient_mortality_flagis drawn on a severity- and type-derived probability; time-to-death is an exponential rather than a fully integrated survival model. Small CURB-65=0 subsets can show noisy mortality at low n (converges to target at scale).
General caveat: cross-field correlations beyond those explicitly modeled may be weaker than in real cohorts. Not for clinical decision-making — research/development use only.
Commercial product comparison
| Capability | This sample | Full HC-RES-003 product |
|---|---|---|
| Patients | 500 | 20,000+ (configurable) |
| Seeds / cohorts | 1 | Multi-seed, reproducible |
| Formats | CSV | CSV + Parquet + JSON |
| Comorbidity model | Marginal draws | Jointly conditioned |
| Mortality | Cross-sectional Bernoulli | Integrated survival model |
| License | CC-BY-NC-4.0 | Commercial |
| Support & SLA | — | Included |
Full product, custom cohorts, or other respiratory SKUs (asthma, COPD, ILD, pulmonary hypertension, sleep apnea): pradeep@xpertsystems.ai
Citation
@dataset{xpertsystems_hc_res_003_2026,
title = {HC-RES-003: Pneumonia Synthetic Dataset},
author = {XpertSystems.ai},
year = {2026},
publisher = {XpertSystems.ai Synthetic Data Factory},
url = {https://xpertsystems.ai},
note = {Synthetic; CC-BY-NC-4.0 (sample). Calibrated to: ATS/IDSA 2019 CAP
guidelines; PSI/Fine score (Fine et al. 1997, NEJM); CURB-65 (Lim et al.
2003, Thorax); SMART-COP (Charles et al. 2008, CID); ARDSNET (NEJM 2000)
and Berlin ARDS definition; RECOVERY trial (Horby et al. 2021, NEJM); CDC
NHSN HAP/VAP surveillance; CMS HRRP readmission benchmarks; Surviving Sepsis
Campaign 2021. Third SKU in the XpertSystems Respiratory vertical.}
}
Synthetic data generated by XpertSystems.ai. Not derived from real patient records. Not for clinical use.
- Downloads last month
- 27